Records containing: RSV Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-02-28Detection of the Human Aerosolization Patterns of Respiratory Syncytial Virus
-
CLINICAL_TRIALS study record update · 2025-01-14Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2024-12-31A Phase 1, Placebo-controlled, Randomized, Observer-blind Study to Describe the Safety, Reactogenicity and Immunogenicity of a Bivalent Recombinant RSV Vaccine (SCB-1019T) in Children 2 to <6 Years of Age
-
CLINICAL_TRIALS study record update · 2024-11-27A Phase-2b Controlled Study to Evaluate the Humoral and Cellular Immune Response and Safety Following One and Two Doses of an Adjuvanted RSV Subunit Vaccine in Immunocompromised Patients Aged 18 Years and Older.
-
CLINICAL_TRIALS study record update · 2024-07-08An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-05-20A Phase 1 Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of RSM01, a Monoclonal Antibody Targeting Respiratory Syncytial Virus, in Healthy Adults
-
CLINICAL_TRIALS study record update · 2024-05-07Respiratory Immune Responses in Human Influenza Virus Infection Across Age to Understand What Dictates Disease Severity
-
CLINICAL_TRIALS study record update · 2024-04-30IVD_ Starfish_Clinical Performance Study Protocol for US - Project STARFISH - PRJ0002679
-
CLINICAL_TRIALS study record update · 2024-04-22Epidemiological and Clinical Characteristics of Hospitalized Patients Under 5 Years Old With RSV Infection in Central China, Wuhan
-
CLINICAL_TRIALS study record update · 2024-03-19RSV Burden in Older Adults in Primary Care in The Netherlands: the RAPID Study
-
CLINICAL_TRIALS study record update · 2024-03-01Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
-
CLINICAL_TRIALS study record update · 2024-02-14Study on the Impact of Coordinated Immunizations Against RSV and Influenza on the Prognosis in Patients With Chronic Heart Failure.
-
CLINICAL_TRIALS study record update · 2024-01-26Sample Collection to Facilitate the Performance Evaluation of the LumiraDx Point of Care Device for the Detection of Influenza A/B, Respiratory Syncytial Virus (RSV) & COVID-19 (SARS-COV-2 Virus)
-
CLINICAL_TRIALS study record update · 2024-01-12Evaluation of Lung Ultrasonography Findings in Newborns With Respiratory Syncytial Virus Bronchiolitis
-
CLINICAL_TRIALS study record update · 2023-12-26Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
-
CLINICAL_TRIALS study record update · 2023-11-15A Phase 2, Open-label, Uncontrolled, Single-dose Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Occurrence of Antidrug Antibody for Nirsevimab in Immunocompromised Children ≤ 24 Months of Age
-
CLINICAL_TRIALS study record update · 2023-09-01A Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, First-In- Human Study of Orally Administered EDP-323 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses, Multiple Ascending Doses, and the Effect of Food on EDP-323 Pharmacokinetics in Healthy Participants
-
CLINICAL_TRIALS study record update · 2023-08-14A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 & FLU A/B Test, and LumiraDx SARS-CoV-2 & RSV Test at Point of Care Testing Sites
-
CLINICAL_TRIALS study record update · 2023-08-03Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, RSV 6120/∆NS2/1030s, Lot RSV#012A, Delivered as Nose Drops to RSV-Seropositive Children 12 to 59 Months of Age and RSV-Seronegative Infants and Children 6 to 24 Months of Age
-
CLINICAL_TRIALS study record update · 2023-07-21A Phase 2a, Randomised, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Immunogenicity and Efficacy of the Recombinant MVA-BN®-RSV Vaccine Against Respiratory Syncytial Virus Infection in the Virus Challenge Model in Healthy Adult Participants
-
CLINICAL_TRIALS study record update · 2023-07-03CSP0010 FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol
-
CLINICAL_TRIALS study record update · 2023-05-08Randomized, Double-blind, Placebo-controlled Trial of the Safety, Tolerability, and Efficacy of RV521 in the Treatment of Adult Subjects Who Have Undergone Hematopoietic Cell Transplantation (HCT) With a Documented Upper Respiratory Tract Infection (URTI) With Respiratory Syncytial Virus (RSV)
-
CLINICAL_TRIALS study record update · 2023-03-28Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.
-
CLINICAL_TRIALS study record update · 2023-03-16Spectrographic and Acoustic Analysis of Lung Sounds Collected by RESP™ Biosensor to Support of Cardiorespiratory Therapeutic Decision Making in Monitored Hospitalized Pediatric Patients
-
CLINICAL_TRIALS study record update · 2022-11-16Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants (Dutch: Naar Levenslang Gezonde LONGen: Een multidiscipLinair zOrgpad Voor te Vroeg Geboren kindEren)